Abstract
Objectives
Contrast-induced nephropathy (CIN) has not been systematically studied in high-risk patients with chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI) for chronic total occlusion (CTO).
Methods
We prospectively observed 515 consecutive patients with CKD undergoing PCI. Patients were divided into three groups: patients who underwent attempted PCI for CTO (group A, n = 85), patients who did not receive PCI for CTO (group B, n = 45) and patients without CTO (group C, n = 385).
Results
CIN developed in 55 patients (10.68 %). Group A patients received a larger CM dose than group B or group C (p = 0.024). The intravenous hydration volume, age and CIN Mehran score were not significantly different between the three groups. The incidence of CIN was 9.4 % for group A, 6.7 % for group B and 11.4 % for group C (p = 0.344). In-hospital mortality and required renal replacement therapy (p = 0.325) were not significantly different between the groups. Multivariate analysis showed that after adjusting for potential confounding factors, the odds ratio for CIN was 1.03 (p = 0.944) for group A and 0.64 for group B (p = 0.489) compared to group C.
Conclusions
Attempts to achieve recanalization of CTO in patients with CKD might not increase the risk of CIN if appropriate preventative measures are taken.
Key Points
• Contrast-induced nephropathy can increase morbidity and mortality
• Chronic kidney disease patients are at the greatest risk of CIN
• Patients with CKD undergoing CTO-PCI are common
• Incidence of CIN has not been reported in CKD patients
• CTO-PCI in CKD patients might not increase the risk of CIN
Similar content being viewed by others
Abbreviations
- AMI:
-
acute myocardial infarction
- CABG:
-
coronary artery bypass graft
- CIN:
-
contrast-induced nephropathy
- CKD:
-
chronic kidney disease
- CM:
-
contrast media
- CTO:
-
chronic total occlusion
- eGFR:
-
estimated glomerular filtrate rate
- LVEF:
-
left ventricular ejection fractions
- PCI:
-
percutaneous coronary intervention
- SCr:
-
serum creatinine
References
Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399
Wi J, Ko YG, Kim JS et al (2011) Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 97:1753–1757
Christofferson RD, Lehmann KG, Martin GV et al (2005) Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol 95:1088–1091
Joyal D, Afilalo J, Rinfret S (2010) Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. Am Heart J 160:179–187
Jones DA, Weerackody R, Rathod K et al (2012) Successful recanalization of chronic total occlusions is associated with improved long-term survival. JACC Cardiovasc Interv 5:380–388
Tajstra M, Gasior M, Gierlotka M et al (2012) Comparison of five-year outcomes of patients with and without chronic total occlusion of noninfarct coronary artery after primary coronary intervention for ST-segment elevation acute myocardial infarction. Am J Cardiol 109:208–213
Weisbord SD, Palevsky PM (2010) Strategies for the prevention of contrast-induced acute kidney injury. Curr Opin Nephrol Hypertens 19:539–549
Bailie GR, Uhlig K, Levey AS (2005) Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease. Pharmacotherapy 25:491–502
Di Mario C, Hildick-Smith D, Gershlick A et al (2013) Highlights from The Experts “Live”, 4th annual congress of the Euro CTO Club, London 2012. EuroIntervention 8:1359–1361
Di Mario C, Werner GS, Sianos G et al (2007) European perspective in the recanalisation of chronic total occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention 3:30–43
Sianos G, Werner GS, Galassi AR et al (2012) Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club. EuroIntervention 8:139–145
Patel MR, Bailey SR, Bonow RO et al (2012) ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/ SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 144:39–71
Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541
Ma YC, Zuo L, Chen JH et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937–2944
McCullough PA, Wolyn R, Rocher LL et al (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368–375
Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930–936
Harkonen S, Kjellstrand CM (1977) Exacerbation of diabetic renal failure following intravenous pyelography. Am J Med 63:939–946
Manske CL, Sprafka JM, Strony JT et al (1990) Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615–620
Dangas G, Iakovou I, Nikolsky E et al (2005) Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95:13–19
Tsai TT, Patel UD, Chang TI et al (2014) Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI Registry. JACC Cardiovasc Interv 7:1–9
Aguiar-Souto P, Ferrante G, Del FF et al (2010) Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions. Int J Cardiol 139:68–74
Patel VG, Brayton KM, Tamayo A et al (2013) Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv 6:128–136
Kini AS, Mitre CA, Kim M et al (2002) A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam. Catheter Cardiovasc Interv 55:169–173
Diaz-Sandoval LJ, Kosowsky BD, Losordo DW (2002) Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89:356–358
Nikolsky E, Mehran R, Turcot D et al (2004) Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94:300–305
Kane GC, Doyle BJ, Lerman A et al (2008) Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. J Am Coll Cardiol 51:89–90
Mercuri M, Xie C, Levy M et al (2009) Predictors of increased radiation dose during percutaneous coronary intervention. Am J Cardiol 104:1241–1244
Morino Y, Kimura T, Hayashi Y et al (2010) In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). JACC Cardiovasc Interv 3:143–151
Tan N, Liu Y, Chen JY et al (2013) Use of the contrast volume or grams of iodine-to-creatinine clearance ratio to predict mortality after percutaneous coronary intervention. Am Heart J 165:600–608
Borgia F, Viceconte N, Ali O et al (2012) Improved cardiac survival, freedom from mace and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions. Int J Cardiol 161:31–38
Mehran R, Claessen BE, Godino C et al (2011) Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv 4:952–961
Weisbord SD, Palevsky PM (2008) Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 3:273–280
Wright RS, Anderson JL, Adams CD et al (2011) 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 57:1920–1959
Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555
Acknowledgments
Ning Tan, Ji-yan Chen, Yong Liu, Yuan-hui Liu conceived and designed the study, analysed and interpreted the data. Yong Liu and Yuan-hui Liu drafted the manuscript and Ying-ling Zhou, Jian-fang Luo, Dan-qing Yu, Li-wen Li, Hua-long Li, Piao-Ye and Peng Ran critically revised the manuscript for intellectual content. Ning Tan approved the final version of the manuscript. All of the authors were involved the manuscript preparation. We appreciate the efforts of our statistical consultant, Prof. Ping-Yan Chen, MS, of the Department of Biostatistics, Southern Medical University, China.
The scientific guarantor of this publication is Ning Tan. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. This study was supported by a grant from the National Natural Science Foundation of China (grant no. 81270286) and Guangdong Cardiovascular Institute, Guangdong Provincial Cardiovascular Clinical Medicine Research Fund (grant no: 2009X41). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Moreover, the work was not funded by any industry sponsors. Prof. Ping-Yan Chen kindly provided statistical advice for this manuscript. Institutional review board approval was obtained. Written informed consent was obtained from all patients in this study.
Methodology: prospective, observational, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Additional information
The first two co-authors contributed equally to this work. Ning Tan and Ji-yan Chen were considered equally as corresponding authors.
Rights and permissions
About this article
Cite this article
Liu, Yh., Liu, Y., Tan, N. et al. Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease. Eur Radiol 25, 2274–2281 (2015). https://doi.org/10.1007/s00330-014-3360-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-014-3360-1